Ad
related to: RHHBY
Search results
RHHBY vs. ABBV: Which Stock Is the Better Value Option?
Zacks via Yahoo Finance· 1 year agoInvestors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard...
Does Roche Holding AG (RHHBY) Have a Pipeline of Opportunities?
Insider Monkey via Yahoo Finance· 5 months agoAriel Investments, an investment management company, released its “Ariel Global Fund” third-quarter...
Roche (RHHBY) Announces 2-Year Data on Vabysmo for nAMD
Zacks via Yahoo Finance· 2 years agoRoche RHHBY has announced new two-year data from the TENAYA and LUCERNE studies on ophthalmology...
Roche (RHHBY) Gets EU Nod for Lunsumio, Tecentriq Label Expansion
Zacks via Yahoo Finance· 2 years agoRoche (RHHBY) obtains EU approval for Lunsumio for the treatment of adult patients with relapsed or...
Roche (RHHBY) Up on Upbeat Data From Combo Drug Cancer Study
Zacks via Yahoo Finance· 9 months agoRoche's (RHHBY) stock jumps 4.3% on Wednesday after the company inadvertently publishes encouraging...
Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) phase III IMbrave050 study, evaluating Tecentriq plus Avastin for treating...
Pharma Stock Roundup: RHHBY's Alzheimer's Study Failure, EU Nod for SNY's Enjaymo
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) late-stage Alzheimer's disease study on key pipeline candidate, gantenerumab fails....
Roche's (RHHBY) sBLA For Polivy Combo Accepted by FDA
Zacks via Yahoo Finance· 2 years agoRoche's (RHHBY) sBLA seeking approval for the use of Polivy in combination with R-CHP for previously...
Roche's (RHHBY) Lunsumio Application Gets Priority Review
Zacks via Yahoo Finance· 2 years agoRoche's (RHHBY) BLA application seeking approval for the use of Lunsumio for relapsed or refractory...
Roche (RHHBY) Announces Positive Results From PNH Studies
Zacks via Yahoo Finance· 11 months agoRoche (RHHBY) crovalimab achieves disease control in paroxysmal nocturnal hemoglobinuria patients in...